Mackenzie Financial Corp Bio N Tech Se Transaction History

Mackenzie Financial Corp

$71.1 Billion
Q4 2024

A detailed history of Mackenzie Financial Corp transactions in Bio N Tech Se stock. As of the latest transaction made, Mackenzie Financial Corp holds 3,903 shares of BNTX stock, worth $385,460. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,903

Previous 3,903 -0.0%

Holding current value

$385,460

Previous $444,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$99.72 - $122.68 $1.93 Million - $2.38 Million	-19,370 Reduced 83.23%	3,903 $444,000
Q3 2024 Nov 13, 2024	BUY	$78.36 - $124.66 $486,380 - $773,764	6,207 Added 36.37%	23,273 $2.76 Million
Q2 2024 Aug 14, 2024	SELL	$80.36 - $102.87 $1.05 Million - $1.34 Million	-13,023 Reduced 43.28%	17,066 $1.37 Million
Q1 2024 May 10, 2024	BUY	$88.96 - $112.35 $730,806 - $922,955	8,215 Added 37.56%	30,089 $2.78 Million
Q4 2023 Jan 30, 2024	BUY	$90.91 - $112.75 $1.52 Million - $1.89 Million	16,743 Added 326.31%	21,874 $2.31 Million
Q3 2023 Oct 25, 2023	BUY	$98.5 - $125.08 $234,430 - $297,690	2,380 Added 86.51%	5,131 $557,000
Q2 2023 Aug 03, 2023	BUY	$102.58 - $129.66 $44,211 - $55,883	431 Added 18.58%	2,751 $296,000
Q1 2023 Apr 24, 2023	SELL	$122.57 - $153.67 $800,382 - $1 Million	-6,530 Reduced 73.79%	2,320 $289,000
Q4 2022 Feb 14, 2023	BUY	$118.43 - $186.05 $81,835 - $128,560	691 Added 8.47%	8,850 $1.33 Million
Q3 2022 Oct 07, 2022	BUY	$127.65 - $183.11 $434,775 - $623,672	3,406 Added 71.66%	8,159 $1.1 Million
Q2 2022 Aug 10, 2022	BUY	$123.25 - $186.24 $394,893 - $596,712	3,204 Added 206.84%	4,753 $709,000
Q1 2022 May 13, 2022	SELL	$126.25 - $231.85 $208,312 - $382,552	-1,650 Reduced 51.58%	1,549 $264,000
Q4 2021 Feb 14, 2022	BUY	$216.64 - $362.52 $462,959 - $774,705	2,137 Added 201.22%	3,199 $825,000
Q3 2021 Nov 08, 2021	BUY	$205.93 - $447.23 $218,697 - $474,958	1,062 New	1,062 $290,000
Q1 2021 May 14, 2021	SELL	$85.73 - $119.5 $214,410 - $298,869	-2,501 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$72.71 - $129.54 $181,847 - $323,979	2,501 New	2,501 $204,000

Others Institutions Holding BNTX

# of Institutions

365

Shares Held

39.7M

Call Options Held

3.01M

Put Options Held

2.01M

View Full List

About BioNTech SE

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $24B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

More about BNTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mackenzie Financial Corp with notifications on news.

Account

Mackenzie Financial Corp Bio N Tech Se Transaction History